Search research articles
Contact Us
Filters
Showing results (631-640 of 652) with videos related to
Page
of 66
Sort By:
Nature Biotechnology
|
October 9, 2018
Comprehensive identification of peptides in tandem mass spectra using an efficient open search engine
Hao Chi, Chao Liu, Hao Yang, et al.
Med (New York, N.Y.)
|
July 10, 2024
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer
Ning Li, Meng Qiu, Yanqiao Zhang, et al.
Nature Cell Biology
|
October 2, 2019
A Pandas complex adapted for piRNA-guided transcriptional silencing and heterochromatin formation
Kang Zhao, Sha Cheng, Na Miao, et al.
Nanophotonics (Berlin, Germany)
|
February 20, 2025
Artificial intelligence driven Mid-IR photoimaging device based on van der Waals heterojunctions of black phosphorus
Ziqian Wang, Huide Wang, Chen Wang, et al.
Nature
|
May 29, 2024
Pro-CRISPR PcrIIC1-associated Cas9 system for enhanced bacterial immunity
Shouyue Zhang, Ao Sun, Jing-Mei Qian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 21, 2020
Prodrug-Loaded Zirconium Carbide Nanosheets as a Novel Biophotonic Nanoplatform for Effective Treatment of Cancer
Quan Liu, Zhongjian Xie, Meng Qiu, et al.
Nature Communications
|
September 7, 2017
pGlyco 2.0 enables precision N-glycoproteomics with comprehensive quality control and one-step mass spectrometry for intact glycopeptide identification
Ming-Qi Liu, Wen-Feng Zeng, Pan Fang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
January 29, 2011
[A multicenter randomized phase III trial of domestic product of rmhTNF in the treatment of non-small cell lung cancer]
Qinghua Zhou, Xi Yan, Li Ren, et al.
The Oncologist
|
January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial
Huabin Hu, Kun Wang, Meijin Huang, et al.
Cancer Medicine
|
July 12, 2019
Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms
Yu Zhang, Liang Shang, Pan-Pan Zhang, et al.
Page
of 66
Search research articles
Search
Showing results (631-640 of 652) with videos related to
Sort By:
Page
of 66
Nature Biotechnology
|
October 9, 2018
Comprehensive identification of peptides in tandem mass spectra using an efficient open search engine
Hao Chi, Chao Liu, Hao Yang, et al.
Med (New York, N.Y.)
|
July 10, 2024
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer
Ning Li, Meng Qiu, Yanqiao Zhang, et al.
Nature Cell Biology
|
October 2, 2019
A Pandas complex adapted for piRNA-guided transcriptional silencing and heterochromatin formation
Kang Zhao, Sha Cheng, Na Miao, et al.
Nanophotonics (Berlin, Germany)
|
February 20, 2025
Artificial intelligence driven Mid-IR photoimaging device based on van der Waals heterojunctions of black phosphorus
Ziqian Wang, Huide Wang, Chen Wang, et al.
Nature
|
May 29, 2024
Pro-CRISPR PcrIIC1-associated Cas9 system for enhanced bacterial immunity
Shouyue Zhang, Ao Sun, Jing-Mei Qian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 21, 2020
Prodrug-Loaded Zirconium Carbide Nanosheets as a Novel Biophotonic Nanoplatform for Effective Treatment of Cancer
Quan Liu, Zhongjian Xie, Meng Qiu, et al.
Nature Communications
|
September 7, 2017
pGlyco 2.0 enables precision N-glycoproteomics with comprehensive quality control and one-step mass spectrometry for intact glycopeptide identification
Ming-Qi Liu, Wen-Feng Zeng, Pan Fang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
January 29, 2011
[A multicenter randomized phase III trial of domestic product of rmhTNF in the treatment of non-small cell lung cancer]
Qinghua Zhou, Xi Yan, Li Ren, et al.
The Oncologist
|
January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial
Huabin Hu, Kun Wang, Meijin Huang, et al.
Cancer Medicine
|
July 12, 2019
Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms
Yu Zhang, Liang Shang, Pan-Pan Zhang, et al.
Page
of 66